May 2026
The global CAR-T therapies for blood cancers market size was evaluated at USD 6.80 billion in 2025 and is predicted to hit around USD 38.40 billion by 2035, growing at a CAGR of 18.90%.
June 2026
The RNA editing therapies market expands with clinical progress in precision therapeutics, rare disease solutions, and gene-based medicine.
May 2026
The global in vivo CAR-T therapy market size was evaluated at USD 650.00 million in 2025 and is predicted to hit around USD 10,841.07 million by 2035, growing at a CAGR of 32.50%.
April 2026
The global B-cell maturation antigen (BCMA) targeted therapies market size was evaluated at USD 5.60 billion in 2025 and is predicted to hit around USD 29.81 billion by 2035, growing at a CAGR of 18.20%.
March 2026
The global oral obesity therapies market size was evaluated at USD 4.35 billion in 2025 and is predicted to hit around USD 9.34 billion by 2035, growing at a CAGR of 7.94%.
February 2026
The U.S. radiopharmaceutical therapies market size is estimated to hit around USD 7.70 billion by 2035 increasing from USD 1.92 billion in 2025, with a CAGR of 14.9%%.
December 2025
The global lentivirus manufacturing for advanced therapies market grows with rising demand for viral vectors supporting gene therapy, CAR-T development, and advanced treatments.
September 2025
The global autologous stem cell and non-stem cell based therapies market size is estimated to hit around USD 25.78 billion by 2034 increasing from USD 8.64 billion in 2024, with a CAGR of 11.55%.
September 2025
The oncology CDMO market is expanding rapidly, fueled by rising cancer prevalence, growing demand for advanced therapies like ADCs and cell & gene therapies, and the increasing need for specialized outsourcing services.
August 2025
The high-potency API (HPAPI) CDMO market is expanding with rising demand for oncology drugs, targeted therapies, and advanced containment solutions.
August 2025
The global histoplasmosis treatment market size reached USD 2.27 billion in 2024 and is projected to surpass around USD 5.38 billion by 2034, with a solid CAGR of 9.01%.
August 2025
The global hepatocyte growth factors (HGFs) market size was valued at USD 72.76 million in 2024 and is expected to hit around USD 122.65 million by 2034, growing at a CAGR of 5.36%.
August 2025
The global liposome drug delivery market size reached USD 5.59 billion in 2024 and is projected to surpass around USD 13.12 billion by 2034, with a CAGR of 8.91%.
July 2025
The global polycystic ovarian syndrome treatment market size was evaluated at USD 4.84 billion in 2024 and is predicted to hit around USD 9.21 billion by 2034, growing at a CAGR of 6.64%.
July 2025
The global cell and gene therapy bioanalytical testing services market size is expected to hit around USD 1,113.86 million by 2034 from USD 548.55 million in 2024, with a CAGR of 7.34%.
July 2025
The non-opioid pain treatment market size was estimated at USD 48.38 billion in 2024 and is projected to hit around USD 96.25 billion by 2034 with a CAGR of 7.12%.
July 2025
The global stem cell banking market size was valued at USD 6.68 billion in 2024 and is expected to surpass around USD 27.71 billion by 2034 with a CAGR of 15.29%.
July 2025
The global venous leg ulcer market size is estimated to hit around USD 8.47 billion by 2034 increasing from USD 2.25 billion in 2024, with a CAGR of 14.18%.
July 2025
The global benign prostatic hyperplasia treatment market size is estimated to hit around USD 21.46 billion by 2034 increasing from USD 12.49 billion in 2024, with a CAGR of 5.56%.
July 2025
The global acute migraine treatment market size was valued at USD 3.46 billion in 2024 and is expected to surge around USD 10.08 billion by 2034 with a CAGR of 11.30%.
July 2025
The prurigo nodularis treatment market size was exhibited at USD 2.22 billion in 2024 and is projected to hit around USD 3.29 billion by 2034 with a CAGR of 4.01%.
June 2025
The global blood platelets market size was estimated at USD 5.72 billion in 2023 and is projected to attain around USD 9.86 billion by 2033 with a CAGR of 5.59%.
June 2025
The global glaucoma treatment market size is expected to attain around USD 8.66 billion by 2034, increasing from USD 6.51 billion in 2024, with a CAGR of 2.86%.
June 2025
The global cancer stem cells market size is anticipated to worth around USD 6.60 billion by 2034 from USD 2.14 billion in 2024 with a CAGR of 11.92%.
June 2025
The global oncology molecular diagnostic market size was valued at USD 2.74 billion in 2024 and is expected to surge around USD 8.50 billion by 2034, at a CAGR of 11.99%.
June 2025
The global topical drugs CDMO market size was exhibited at USD 46.62 billion in 2024 and is predicted to surpass around USD 136.39 billion by 2034, with a CAGR of 11.33%.
June 2025
The global inhalable drugs market size was valued at USD 35.44 billion in 2024 and is projected to cross around USD 65.51 billion by 2034 with a CAGR of 5.57%.
June 2025
The global microwave ablation devices market size is estimated to hit around USD 1,466.66 million by 2034 increasing from USD 450.05 million in 2024, with a CAGR of 12.54%.
July 2024
The global recombinant antibodies market size was estimated at USD 12.40 billion in 2023 and is projected to surpass around USD 23.34 billion by 2033 with a CAGR of 6.53%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com